ASDr. Ahmed ShihabConsultant Anesthesiologist – Baghdad عربي

Antiemetic Drugs in Anaesthetic Practice: Physiological Foundations and Clinical Applications

Topic notes · Basic Sciences · Perioperative drugs

Postoperative nausea and vomiting (PONV) is one of the most distressing complications encountered by patients during the postoperative period. Successful prevention and management necessitate a solid understanding of the neural pathways coordinating emesis and the diverse pharmacologic classes targeting these receptors.

Neurophysiology of Vomiting and the Chemoreceptor Trigger Zone

Vomiting is coordinated by efferent neurons located in the medulla oblongata within a specialized vomiting centre. This centre receives inputs from the chemoreceptor trigger zone (CTZ) situated in the area postrema on the caudal floor of the fourth ventricle, which lies functionally outside the blood-brain barrier. The CTZ possesses high concentrations of dopamine D2, 5-HT3, and opioid receptors. Furthermore, the gastrointestinal tract initiates emetic signals when 5-hydroxytryptamine released from enterochromaffin cells stimulates 5-HT3 receptors on vagal afferents, whereas motion sickness involves vestibular nuclei utilizing cholinergic and histamine H1 receptors to transmit impulses.

Serotonin 5-HT3 Receptor Antagonists

Antiemetics are classified by receptor targets into dopamine antagonists, 5-HT3 antagonists, anticholinergics, antihistamines, and miscellaneous agents. Ondansetron is a synthetic carbazole that blocks 5-HT3 receptors on vagal terminals and the CTZ, administered IV/IM at 4 to 8 mg (or orally at 8-16 mg before the end of surgery). It has 60% oral bioavailability, 76% protein binding, and an elimination half-life of 3-6 hours via hepatic metabolism, with common side effects including headache, flushing, bradycardia, and constipation. Granisetron achieves PONV prevention at a minimal effective dose of 1 mg and is metabolized by CYP3A4 without CYP2D6 involvement, whereas ondansetron and dolasetron rely on CYP2D6 (dolasetron minimal dose being 12.5 mg). Palonosetron exhibits exceptional binding, with 2500-fold higher affinity for 5-HT3 receptors than serotonin and 100-fold higher affinity than other 5-HT3 antagonists.

Dopamine Antagonists, Prokinetics, and Black Box Warnings

Droperidol exerts antiemetic activity via dopamine blockade in the CTZ at an IV/IM dose of 0.625 to 1.25 mg, achieving optimal efficacy when given at the end of surgery; however, it carries an FDA black box warning for QT prolongation and torsade de pointes with an elimination half-life of 2.3 hours. Metoclopramide is a benzamide D2 blocker that accelerates gastric emptying and increases lower esophageal sphincter tone at adult doses of 10-20 mg every 4-6 hours, but carries a black box warning for potentially irreversible tardive dyskinesia. Prochlorperazine acts via CTZ dopaminergic blockade dosed at 2.5-10 mg IV (maximum 40 mg/day). In addition, Propofol provides antiemesis at an IV dose of 10-20 mg.

Corticosteroids, Antihistamines, Anticholinergics, and Risk Stratification

Dexamethasone is administered before incision at 4 to 8 mg IV (or 4 to 5 mg at induction), providing a biological half-life of 36-54 hours and efficacy comparable to ondansetron 4 mg. When coadministered with the oral NK1 antagonist Aprepitant (40 mg), dexamethasone doses must be halved due to CYP3A4 inhibition by aprepitant, whereas ondansetron pharmacokinetics remain unaltered. Among antihistamines, Promethazine carries black box warnings against use in children under 2 years due to fatal respiratory depression, and for severe tissue necrosis requiring amputation following extravasation. Cyclizine is dosed at 50 mg, and Dimenhydrinate at 60 mg (equivalent to 30 mg diphenhydramine). Transdermal scopolamine base (1.5 mg patch) requires caution in narrow-angle glaucoma, whereas glycopyrrolate lacks antiemetic action because it does not cross the blood-brain barrier. Clinically, the Apfel score utilizes 4 independent predictors (female sex, nonsmoking status, history of PONV/motion sickness, and postoperative opioids) predicting risk rates of approximately 10%, 20%, 40%, 60%, and 80%.

Key points
  • The CTZ is located in the area postrema of the fourth ventricle outside the blood-brain barrier and is rich in D2, 5-HT3, and opioid receptors.
  • Black box warnings apply to droperidol (QT prolongation), metoclopramide (tardive dyskinesia), and promethazine (fatal respiratory depression in children <2 y and extravasation necrosis).
  • Coadministration of the NK1 antagonist aprepitant necessitates halving the dexamethasone dose due to CYP3A4 enzyme inhibition.
  • Atropine and hyoscine cross the blood-brain barrier exerting antiemetic effects, whereas glycopyrrolate does not.
  • The Apfel score stratifies PONV risk at roughly 10%, 20%, 40%, 60%, and 80% corresponding to 0, 1, 2, 3, or 4 independent risk factors.

Sources

  • Dr Podcast Scripts for the Primary FRCA, p. 241
  • Dr Podcast Scripts for the Primary FRCA, p. 242
  • Dr Podcast Scripts for the Primary FRCA, p. 243
  • Clinical Anesthesia, p. 1307
  • Clinical Anesthesia, p. 1308
  • Pharmacology and Physiology for Anesthesia, p. 505
  • Pharmacology and Physiology for Anesthesia, p. 511
  • Pharmacology and Physiology for Anesthesia, p. 514
  • Anesthesia Review: Blasting the Boards, p. 49

Test yourself: 15 questions on this topic and many more →

Educational content for healthcare staff and students. It does not replace clinical judgement or your hospital protocol; check any dose against the reference and local guidance before use.